A carregar...

Blockade of the B7-H1/PD-1 Pathway for Cancer Immunotherapy

The aim of cancer immunotherapy is to treat malignant disease by inducing or enhancing cancer specific immune responses. With the identification of tumor-associated antigens (TAAs) in the 1990s, cancer immunotherapy research largely focused on inducing immune responses against TAAs but achieved limi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Flies, Dallas B., Sandler, Britt J., Sznol, Mario, Chen, Lieping
Formato: Artigo
Idioma:Inglês
Publicado em: YJBM 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3238327/
https://ncbi.nlm.nih.gov/pubmed/22180678
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!